The internal dosimetry user group position statement on molecular radiotherapy.
Embargo End Date
ICR Authors
Authors
Gear, J
McGowan, D
Rojas, B
Craig, AJ
Smith, A-L
Scott, CJ
Scuffam, J
Aldridge, M
Tipping, J
McGowan, D
Rojas, B
Craig, AJ
Smith, A-L
Scott, CJ
Scuffam, J
Aldridge, M
Tipping, J
Document Type
Journal Article
Date
2021-10-01
Date Accepted
2021-07-05
Abstract
The Internal Dosimetry User Group (IDUG) is an independent, non-profit group of medical professionals dedicated to the promotion of dosimetry in molecular radiotherapy (www.IDUG.org.uk). The Ionising Radiation (Medical Exposure) Regulations 2017, IR(ME)R, stipulate a requirement for optimisation and verification of molecular radiotherapy treatments, ensuring doses to non-target organs are as low as reasonably practicable. For many molecular radiotherapy treatments currently undertaken within the UK, this requirement is not being fully met. The growth of this field is such that we risk digressing further from IR(ME)R compliance potentially delivering suboptimal therapies that are not in the best interest of our patients. For this purpose, IDUG proposes ten points of action to aid in the successful implementation of this legislation. We urge stakeholders to support these proposals and ensure national provision is sufficient to meet the criteria necessary for compliance, and for the future advancement of molecular radiotherapy within the UK.
Citation
British Journal of Radiology
DOI
Source Title
Publisher
Oxford University Press (OUP)
ISSN
0007-1285